Literature DB >> 23279297

Comparing dose prediction software used to manage gentamicin dosing.

C Wong1, S S Kumar, G G Graham, E J Begg, P K L Chin, J Brett, J E Ray, D J E Marriott, K M Williams, R O Day.   

Abstract

BACKGROUND: Current Australian guidelines recommend initiating directed therapy of gentamicin if administration exceeds 48 h. Directed doses of gentamicin require the monitoring of plasma concentrations of gentamicin to determine the 24-h area under the time course of plasma gentamicin concentrations (AUC) and a dosage prediction program, for example TCIWorks or Aladdin. However, doses calculated by such programs have not been compared with an established program. AIM: To compare the directed dosage of gentamicin calculated by TCIWorks, Aladdin and an Excel-based program, with an established program, Abbottbase.
METHODS: Peak and trough plasma concentrations after the first and second administered doses of gentamicin were available from three patient groups (n = 20-23) with varying creatinine clearances (<40, 40-80, >80 mL/min). The directed dose needed to produce 24-h AUC values of 80 mg.h/L was calculated using each program.
RESULTS: There was a strong correlation between the directed doses predicted by each of the three programs compared with Abbottbase, following the first administered dose (r(2) > 0.97, P < 0.0001). The mean ratio (90% confidence intervals) of these directed doses of the gentamicin were: TCIWorks/Abbottbase 106% (105-107%), Aladdin/Abbottbase 102% (101-103%) and Excel/Abbottbase 108% (106-109%). The correlations and dose ratios were also similar when comparisons were made following the second administered dose. For each of the three renal function groups, all programs yielded similar directed doses.
CONCLUSIONS: The four programs used in the calculation of directed doses of gentamicin yielded similar results. Any would be suitable for use in clinical practice.
© 2012 The Authors; Internal Medicine Journal © 2012 Royal Australasian College of Physicians.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23279297     DOI: 10.1111/imj.12067

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  4 in total

1.  Therapeutic drug monitoring of once daily aminoglycoside dosing: comparison of two methods and investigation of the optimal blood sampling strategy.

Authors:  Lana Nezic; Adrian Derungs; Marcel Bruggisser; Sarah Tschudin-Sutter; Stephan Krähenbühl; Manuel Haschke
Journal:  Eur J Clin Pharmacol       Date:  2014-04-23       Impact factor: 2.953

2.  Evaluation of Tobramycin Exposure Predictions in Three Bayesian Forecasting Programmes Compared with Current Clinical Practice in Children and Adults with Cystic Fibrosis.

Authors:  Marc Burgard; Indy Sandaradura; Sebastiaan J van Hal; Sonya Stacey; Stefanie Hennig
Journal:  Clin Pharmacokinet       Date:  2018-08       Impact factor: 6.447

Review 3.  Dashboard systems: implementing pharmacometrics from bench to bedside.

Authors:  Diane R Mould; Richard N Upton; Jessica Wojciechowski
Journal:  AAPS J       Date:  2014-06-20       Impact factor: 4.009

4.  Multidrug Resistant Pseudomonas Mycotic Pseudoaneurysm following Cardiac Transplant Bridged by Ventricular Assistant Device.

Authors:  C Aye; M Williams; R Horvath
Journal:  Case Rep Infect Dis       Date:  2017-03-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.